Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Eton Pharmaceuticals
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
August 27, 2026
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 13, 2026
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
August 5, 2026
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
August 3, 2026
Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
July 29, 2026
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
May 26, 2026
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
May 25, 2026
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
May 24, 2026
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
May 24, 2026
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
May 23, 2026
1
2
Next Page
→